Science Explorer Back to mapMap
Discussion
Topic · Rheumatology

Bone Tumor Diagnosis and Treatments

Bone Tumor Diagnosis and Treatments is a research topic within Rheumatology. Science Explorer counts 34k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, treatment, and molecular understanding of various bone tumors and tumor-like conditions in the skeletal system, including chondrosarcoma, chordoma, osteoid osteoma, giant cell tumor, fibrous dysplasia, aneurysmal bone cyst, Ollier disease, Maffucci syndrome, enchondroma, and mesenchymal chondrosarcoma.

  • Chondrosarcoma
  • Chordoma
  • Osteoid Osteoma
  • Giant Cell Tumor
  • Fibrous Dysplasia
  • Aneurysmal Bone Cyst
  • Ollier Disease
  • Maffucci Syndrome
  • Enchondroma
  • Mesenchymal Chondrosarcoma
Research works
34k
fractional, since 1950
In the world top 10%
3.4k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+2%
the tick is no change
Largest producer
United States
27% of the 10 largest, 2022-now
Bone Tumor Diagnosis and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Bone Tumor Diagnosis and Treatments research?

By volume, the United States and India publish the most (1k and 857 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1k works
  2. 2 India 857 works
  3. 3 China 622 works
  4. 4 Japan 323 works
  5. 5 Türkiye 203 works
  6. 6 Brazil 199 works
  7. 7 Italy 183 works
  8. 8 United Kingdom 167 works
  9. 9 Germany 139 works
  10. 10 France 133 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 26.8%India: 22.2%China: 16.1%Japan: 8.4%6 others listed: 26.5%27%largest
United States1,037 · 26.8%India857 · 22.2%China622 · 16.1%Japan323 · 8.4%6 others listed1,025 · 26.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Bone Tumor Diagnosis and Treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Bone Tumor Diagnosis and Treatments research, followed by Harvard University and Peking University.

Who are the leading researchers in Bone Tumor Diagnosis and Treatments?

The most-cited researchers publishing on Bone Tumor Diagnosis and Treatments include Bert Vogelstein, Gad A. Getz and Cyrus Cooper.

  1. 1 Bert Vogelstein United States 373k citations
  2. 2 Gad A. Getz United States 364k citations
  3. 3 Cyrus Cooper United Kingdom 342k citations
  4. 4 Jun Wang China 340k citations
  5. 5 Dan J. Stein South Africa 306k citations
  6. 6 Kenneth W. Kinzler United States 253k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Bone Tumor Diagnosis and Treatments?

The most cited paper in Bone Tumor Diagnosis and Treatments is "A System for the Surgical Staging of Musculoskeletal Sarcoma" (William F. Enneking, Suzanne S. Spanier, MARK A. GOODMAN, 1980), with 2,513 citations. Next come "A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System" (2,226) and "Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols" (1,872).

Most cited papers
#PaperReleasedCitations
1 A System for the Surgical Staging of Musculoskeletal Sarcoma William F. Enneking, Suzanne S. Spanier, MARK A. GOODMAN · Clinical Orthopaedics and Related Research Nov 1980 2,513
2 A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System WILLIAM F. ENNEKING, WILLIAM DUNHAM, Mark C. Gebhardt et al. · Clinical Orthopaedics and Related Research 1993 2,226
3 Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Stefan S. Bielack, Beate Kempf‐Bielack, G. Delling et al. · Journal of Clinical Oncology Feb 2002 1,872
4 A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System Craig Gerrand, Kenneth Samora Rankin Book chapter 7 Dec 2013 1,797
5 Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome Lee Scott Weinstein, Andrew Shenker, Pablo V. Gejman et al. · New England Journal of Medicine 12 Dec 1991 1,716
All 98 most cited papers, with filters and sorting

Where is Bone Tumor Diagnosis and Treatments research done?

The largest centres of Bone Tumor Diagnosis and Treatments research in 2022-now are Beijing (China), New Delhi (India), Istanbul (Türkiye) and Chennai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Wardha and Rabat.

Largest cities, 2022-now

  1. 1 BeijingChina 110 works
  2. 2 New DelhiIndia 81 works
  3. 3 IstanbulTürkiye 71 works
  4. 4 ChennaiIndia 65 works
  5. 5 TokyoJapan 63 works
  6. 6 ShanghaiChina 59 works
  7. 7 New YorkUnited States 59 works
  8. 8 MoscowRussia 51 works
  9. 9 LondonUnited Kingdom 51 works
  10. 10 SeoulSouth Korea 49 works

Where it is the local speciality

  1. WardhaIN · 24.8 works19×
  2. RabatMA · 29.5 works8.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Bone Tumor Diagnosis and Treatments than the world average.

See Bone Tumor Diagnosis and Treatments on the map

Where is the best place to study Bone Tumor Diagnosis and Treatments?

Among universities, judged by research, Leiden University, Harvard University and All India Institute of Medical Sciences score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.63%fractional works in this field (log) →share of work in the world top 10% →Leiden UniversityHarvard UniversityUniversity of MiamiAll India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Leiden UniversityNetherlands 60.339.7%5.0×13 -26.5%
2Harvard UniversityUnited States 55.923.1%2.9×45 -16.2%
3All India Institute of Medical SciencesIndia 53.62.6%16.7×90 +89.8%
4University of MiamiUnited States 51.021.7%6.6×20 +67.7%
5Capital Medical UniversityChina 45.717.7%5.5×28 +11.4%
6Peking UniversityChina 44.614.5%4.5×44 -36.0%
7Sichuan UniversityChina 44.514.5%2.8×30 +50.1%
8Stanford UniversityUnited States 44.022.6%1.8×13 +19.9%
9Johns Hopkins UniversityUnited States 43.617.9%2.8×21 -5.6%
10University of TorontoCanada 41.322.0%1.7×17 -10.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Bone Tumor Diagnosis and Treatments, country by country

Is Bone Tumor Diagnosis and Treatments research growing?

Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Bone Tumor Diagnosis and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Bone Tumor Diagnosis and Treatments as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%0.060%Bone Tumor Diagnosis and Treatments0.022% in 202519801990200020102020

Fractional works of Bone Tumor Diagnosis and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Bone Tumor Diagnosis and Treatments10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Bone Tumor Diagnosis and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.